Calithera Biosciences Inc

NASDAQ:CALA  
1.88
-0.04 (-2.08%)
Earnings Announcements

Calithera Biosciences Reports Fourth Quarter 2020 Financial Results And Recent Highlights

Published: 03/16/2021 23:08 GMT
Calithera Biosciences Inc (CALA) - Calithera Biosciences Reports Fourth Quarter 2020 Financial Results and Recent Highlights.
Calithera Biosciences Inc - Cash, Cash Equivalents and Investments Totaled $115.2 Million at December 31, 2020.
Calithera Biosciences - Believes Cash, Cash Equivalents, Investments at Dec 31, 2020 Will Be Enough to Meet Its Current Operating Plan Through 2022.
Calithera Biosciences Inc - Qtrly Loss per Share $0.32.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.21

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.